UK food prices set to rise 50% by November
UK food prices are projected to rise by 50% by November compared to levels at the start of the cost-of-living crisis in mid-2021, according to the Energy and Climate Intelligence Unit (ECIU). This increase, driven by extreme weather, global supply disruptions, and volatile oil and gas markets, would mean that food price growth seen over the previous two decades would be achieved in just over five years. Staples such as pasta, frozen vegetables, and olive oil have already seen price increases ranging from 50% to 113%, contributing to an average rise in household food bills of £605 over 2022 and 2023.
UK Airport Jobs Threatened by Airline Schedule Cuts
Thousands of UK airport jobs are at risk as airlines reduce flight schedules due to disruptions linked to the Iran conflict, prompting calls for government support from ground handling firms and unions. These groups warn that the employment impact could rival or exceed that of the pandemic, as the sector, which employs around 30,000 people, faces significant revenue pressures with fixed staffing costs remaining despite fewer flights. The government is being urged to consider reintroducing a furlough-style scheme to prevent job losses, as industry data indicates the UK is particularly vulnerable to fuel supply shocks.
Conservative Party proposes changes to household benefit cap
The Conservative Party, led by Kemi Badenoch, has proposed an overhaul of the household benefit cap, aiming to close a £1 billion loophole in the welfare system by tightening exemptions for working-age adults. The plan, which targets households where adults are not employed for at least 16 hours a week, is expected to save at least £1 billion annually and affect over 300,000 households. Critics, including the Labour Party, argue that the changes could disproportionately impact families with disabled children and low-income households.
NHS England launches rapid injectable pembrolizumab for cancer patients
NHS England has begun rolling out a new injectable form of pembrolizumab (Keytruda), an immunotherapy drug that can reduce treatment time for cancer patients by up to 90%. The jab, which can be administered in just one to two minutes, is expected to benefit around 14,000 patients annually across the UK, allowing for quicker treatment and recovery while freeing up hospital resources. This innovation follows the introduction of similar injectable treatments and aims to improve patient experience and NHS productivity.
